Development of Budesonide Loaded Biopolymer Based Dry Powder Inhaler: Optimization, In Vitro Deposition, and Cytotoxicity Study
Figure 7
Percentage cell viability against alveolar epithelial cancer cell line A549 of formulated budesonide and blank DPI and its excipients. Data are presented as mean ± SD, .